<DOC>
	<DOCNO>NCT00965848</DOCNO>
	<brief_summary>The purpose study assess safety efficacy doripenem participant nosocomial pneumonia ( inflammation lung lungs become heavy ; pneumonia occur least 48 hour hospital admission ) , complicate intra-abdominal ( belly ) infection complicate urinary tract infection ( bladder infection ) .</brief_summary>
	<brief_title>A Safety Efficacy Study Doripenem Participants With Nosocomial Pneumonia , Complicated Intra-Abdominal Infections Urinary Tract Infections</brief_title>
	<detailed_description>This open-label ( people involve know identity intervention ) , multi-center ( conducted 1 center ) study , evaluate safety effectiveness doripenem treat Thai participant nosocomial pneumonia , complicate intra-abdominal urinary tract infection . The study consist 4 visit : Visit 1 ( Baseline ) , Visit 2 ( End-of-Treatment [ EOT ] , Day 14 ) , Visit 3 ( Phone visit , Test-of-Cure [ TOC ] , Day 14 EOT ) Visit 4 ( Phone visit , Day 90 ) . Participants receive 500 milligram ( mg ) doripenem intravenous infusion ( directly vein ) every 8 hour least 3 day clinical response extend 14 day . Efficacy primarily evaluate determination clinical response . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<criteria>Eligibility Criteria : Male female participant 18 year old age Diagnosed nosocomial pneumonia , complicate intraabdominal infection complicate urinary tract infection Must evidence systemic inflammatory response syndrome least one : fever ( body temperature great 38 degree celcius ) hypothermia ( body temperature le 36 degree celcius ) elevate total peripheral white blood cell count great equal 12,000 cell per cubic millimeter leukopenia le 4,000 cell per cubic millimeter decrease blood pressure relative Baseline great 15 millimeter mercury systolic increase pulse great 100 beat per minute ( bpm ) respiratory rate great 20 bpm Candidate treatment carbapenems , least one condition : Empirical therapy ; suspect infection cause carbapenem susceptible P. aeruginosa carbapenemsusceptible A. baumannii MDR gram negative bacteria nosocomial infection failure previous treatment modify therapy ; know pathogen resistance cephalosporin , aminoglycosides , fluoroquinolones betalactam/ batalactamase intibitor susceptible carbapenem know infection cause gram negative bacteria Signed informed consent Pregnant lactate female participant History severe allergy antibiotic penicillin , cephalosporin carbapenems Hypersensitivity doripenem and/or excipients Previous use carbapenems within 7 day study entry Participants terminal stage malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Pneumonia , Ventilator-Associated</keyword>
	<keyword>Intra-abdominal Infections</keyword>
	<keyword>Urinary tract Infections</keyword>
	<keyword>Doripenem</keyword>
	<keyword>Doribax</keyword>
</DOC>